Differential Effect of apoE isoform on cholesterol-loaded macrophage
apoE 亚型对胆固醇负载巨噬细胞的不同作用
基本信息
- 批准号:10671058
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Apolipoprotein E (apoE) plays a key role in the lipoprotein metabolism and atherosclerotic diseases. There exist three major common isoforms in human apoE, i.e., E2, E3 and E4. These isoforms have been known to have differential effect on lipoprotein metabolism and atherosclerosis. In the present study, in order to investigate the roles of these isoforms on 1) the reverse cholesterol transport from the macrophages and 2) VLDL-triglycerides lipolysis, we utilized adenoviral vector for the expression of these isoforms.The RAW264.7 mouse macrophage cell line, which does not express apoE endogenously, was cholesterol-loaded. After loading cholesterol, the cells were infected with adenoviral vectors to express apoE isoforms. The expression of apoE2 reduced cellular esterified-cholesterol levels significantly compared with control cells infected with LacZ adenovirus. ApoE3 and E4 also reduced the cellular cholesterol content, however, their effect was not so much effective as apoE2. In the n … More ext experiment, cholesterol-loaded RAW264.7 cells were incubated with the medium harvested from the HeLa cells previously infected with apoE adenovirus, in order to elucidate the role of exogenous apoE on reverse cholesterol transport. This experiment revealed that apoE3 is effective in the reverse cholesterol transport, however, apoE2 and E4 have little effect. Finally, to elucidate the role of apoE on VLDL-triglycerides lipolysis, adenoviral vectors were injected to apoE/LDL-receptor double deficient mice and apoE-containing VLDL was obtained. These VLDL particles were subjected to in vitro lipolysis assay with bovine lipoprotein lipase, with changing the ratio of apoE/TG. This experiment revealed that the existence of apoE on VLDL particles inhibits lipolysis regardless of its isoform, and increasing ratio of apoE2/TG had more inhibitory effect on the lipolysis compared with E3 and E4.In summary, apoE isoforms have differential effect on reverse cholesterol transport from macrophages not only when they were expressed endogenously but also when they were added exogenously. The VLDL-lipolysis is inhibited by apoE regardless of its isoform, and apoE2 has more substantial inhibitory effect compared with the other two isoforms. Less
载脂蛋白E(APOE)在脂蛋白代谢和动脉粥样硬化疾病中起关键作用。人apoe中存在三个主要的共同亚型,即E2,E3和E4。已知这些同工型对脂蛋白代谢和动脉粥样硬化具有差异作用。 In the present study, in order to investigate the roles of these isoforms on 1) the reverse cholesterol transport from the macrophages and 2) VLDL-triglycerides lipolysis, we utilized adenoviral vector for the expression of these isoforms.The RAW264.7 mouse macrophage cell line, which does not express apoE endogenously, was cholesterol-loaded.加载胆固醇后,用腺病毒载体感染细胞以表达APOE同工型。与感染LACZ腺病毒的对照细胞相比,APOE2的表达降低了细胞酯化胆固醇水平。 APOE3和E4还降低了细胞胆固醇含量,但是它们的作用并不像APOE2那样有效。在N…更多的Ext实验中,将胆固醇载的RAW264.7细胞与先前感染APOE腺病毒的HeLa细胞收获的培养基一起孵育,以阐明外源APOE在反向胆固醇转运中的作用。该实验表明,APOE3在反向胆固醇转运方面有效,但是,APOE2和E4的作用很小。最后,为了阐明APOE在VLDL-甘油三酸酯脂解中的作用,将腺病毒载体注射到APOE/LDL受体双受体双缺陷小鼠中,并获得了含APOE的VLDL。将这些VLDL颗粒用牛脂蛋白脂肪酶进行体外脂肪分解测定,并改变APOE/TG的比例。该实验表明,在VLDL颗粒上的APOE存在抑制脂肪分解不管其同工型如何,并且与E3和E4.的apoE2/Tg的增加对脂肪分解具有更大的抑制作用,与E3和E4. IN摘要相比,ApoE同工型在杂酚醇从杂物中的反向转运时具有相差的效果,而在杂噬细胞中也不得不exepersepersepersepersepersepersepers exenoge。与其他两个同工型相比,APOE抑制VLDL-脂解会被APOE抑制,并且APOE2具有更大的抑制作用。较少的
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tangirala R.K., Tsukamoto K. et al.: "Regression of atherosclerosis induced by liver-directed gene transfer of apulipoprotein A-I in mice"Circulation. 100・17. 1816-1822 (1999)
Tangirala R.K.、Tsukamoto K. 等人:“小鼠中载脂蛋白 A-I 的肝脏定向基因转移诱导的动脉粥样硬化的消退”循环 100・17(1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tangirala R. K. Tsukamoto K. et al: "Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice."Circulation. 100. 1816-1822 (1999)
Tangirala R. K. Tsukamoto K. 等人:“小鼠中载脂蛋白 A-I 的肝脏定向基因转移诱导的动脉粥样硬化的消退。”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsukamoto K., et al.: "Hepatic expression of Apolipoprotein E inhibits progression of Atherosclerosis without reducing cholesterol levels in LDL receptor deficient mice"Molecular Therapy. 1. 189-194 (2000)
Tsukamoto K.等人:“载脂蛋白E的肝脏表达抑制动脉粥样硬化的进展,而不降低LDL受体缺陷小鼠的胆固醇水平”分子疗法。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsukamoto K. et al.: "Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isotorms in apoE deficient mice"Journal of Lipid Research. 41・2. 253-259 (2000)
Tsukamoto K.等人:“载脂蛋白E缺陷型小鼠的基因转移诱导VLDL甘油三酯的分泌显着增加”,脂质研究杂志41·2(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Satoh H., Tsukamoto K. et al.: "Thiazolidinediones supress endothelial-I secretion from bovine vascular endothelial cells"Biochemical & Biophysical Research Communications. 254・3. 757-763 (1999)
Satoh H.,Tsukamoto K.等:“噻唑烷二酮抑制牛血管内皮细胞分泌内皮-I”,生物化学与生物物理研究通讯254・3(1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUKAMOTO Kazuhisa其他文献
TSUKAMOTO Kazuhisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUKAMOTO Kazuhisa', 18)}}的其他基金
Verification of Apolipoprotein D as a Chronic Inflammatory Marker, and Analysis of its Physiological Function
载脂蛋白D作为慢性炎症标志物的验证及其生理功能分析
- 批准号:
16K15330 - 财政年份:2016
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Examination of non-cholesterol sterols as biomarkers for insulin resistance and inflammation
检查非胆固醇甾醇作为胰岛素抵抗和炎症的生物标志物
- 批准号:
26670285 - 财政年份:2014
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Modulation of endoplasmic reticulum stress by modification of cholesterol contents in liver.
通过改变肝脏中的胆固醇含量来调节内质网应激。
- 批准号:
23591333 - 财政年份:2011
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses on the mechanisms for cholesterol excretion from liver.
肝脏排泄胆固醇的机制分析
- 批准号:
20591079 - 财政年份:2008
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Plant Sterol and Sterolin in Macrophages and T Lynphocytes
植物甾醇和甾醇在巨噬细胞和 T 淋巴细胞中的作用
- 批准号:
18590977 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Oxidative stress, lipid hyperoxides and diabetic nephropathy
氧化应激、脂质过氧化物和糖尿病肾病
- 批准号:
15590931 - 财政年份:2003
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The analysis of reverse cholesterol system in apolipoprotein A-1 deficiency
载脂蛋白A-1缺乏症的逆胆固醇系统分析
- 批准号:
13672414 - 财政年份:2001
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
HDL, paraoxonase and atherosclerosis
HDL、对氧磷酶和动脉粥样硬化
- 批准号:
12671101 - 财政年份:2000
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
变刚度承载-耗能型连接装配式联肢复合墙协同工作机理与设计方法研究
- 批准号:52308203
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大跨度纵飘桥梁水平双向复合型减振/震系统协同工作机理和优化设计研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
大跨度纵飘桥梁水平双向复合型减振/震系统协同工作机理和优化设计研究
- 批准号:52278232
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
基于三代测序全长转录组的特异性Isoform识别方法研究及特征分析
- 批准号:31760316
- 批准年份:2017
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
沟谷堆积体与微型抗滑桩群协同工作的宏细观机理及设计理论
- 批准号:U1765107
- 批准年份:2017
- 资助金额:49.0 万元
- 项目类别:联合基金项目
相似海外基金
Atherosclerosis Peripheral Nervous System Crosstalk in Apolipoprotein E-deficient and Human Apolipoprotein E Isoform-specific Knock-in Mice
载脂蛋白 E 缺陷和人载脂蛋白 E 亚型特异性敲入小鼠中的动脉粥样硬化周围神经系统串扰
- 批准号:
283608620 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Research Grants
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
8744260 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
9104070 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
9291405 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
8894356 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别: